Drugs that contain Levalbuterol Tartrate
1. Drug name - XOPENEX HFA
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US7256310 | SUNOVION | Levalbuterol salt |
Oct, 2024
(2 years from now) | |
| EP1671942B1 | SUNOVION | Aerosol Formulation Comprising Levalbuterol L-Tartrate Salt |
Dec, 2023
(1 year, 2 months from now) | |
| EP1572622A1 | SUNOVION | Use Of Levalbuterol L-Tartrate In The Production Of A Metered Dose Inhaler |
Dec, 2023
(1 year, 2 months from now) | |
| EP2292584B1 | SUNOVION | Pharmaceutical Composition Comprising Levalbuterol L-Hemitartrate Salt As Aerosol Formulation |
Dec, 2023
(1 year, 2 months from now) | |
| EP2292584A1 | SUNOVION | Pharmaceutical Composition Comprising Levalbuterol L-Hemitartrate Salt As Aerosol Formulation |
Dec, 2023
(1 year, 2 months from now) | |
| EP1671942A1 | SUNOVION | Aerosol Formulation Comprising Levalbuterol L-Tartrate Salt |
Dec, 2023
(1 year, 2 months from now) | |
| EP1572622B1 | SUNOVION | Use Of Levalbuterol L-Tartrate In The Production Of A Metered Dose Inhaler |
Dec, 2023
(1 year, 2 months from now) | |
| EP1671942B2 | SUNOVION | Aerosol Formulation Comprising Levalbuterol L-Tartrate Salt |
Dec, 2023
(1 year, 2 months from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8765153 | SUNOVION | Levalbuterol salt |
Dec, 2023
(1 year, 2 months from now) | |
Treatment: NA
Dosage: AEROSOL, METERED;INHALATION
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| EQ 0.045MG BASE/INH | AEROSOL, METERED;INHALATION | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.